The safety and efficacy of the device were assessed in 1968 neonates with gestational ages ranging from 28 to 41 weeks and suffering from incidences of hyperbilirubinemia. The study was aimed to evaluate the performance of a newly developed non-invasive and non-contact bilirubin measurement device (AJO-Neo) as an alternative to the conventional invasive biochemical method of total serum bilirubin (TSB) estimation in preterm and term neonates suffering from hyperbilirubinemia associated with risk factors, and/or undergoing phototherapy. This contribution is an extension of the Intelligent Sensors and Monitoring System for Low-cost Phototherapy Light for Jaundice Treatment that was presented in the International Symposium on Multimedia and Communication Technology (ISMAC) in 2019. Its solar-power features for off-grid and remote deployments were also explored. The system is envisioned to be integrated with Mobile or Near Cloud as part of Smart Nursing Station together with other hospital equipment for monitoring, collection, and management of medical records and services. Developing this tool will help determine the intensity of yellowish color in infants and can monitor NNJ in a non-invasive way. This paper showcases our previous and continuously improving development at Ateneo Innovation Center (AIC) and partners in designing and further enhancing the existing Low-cost Phototherapy Light System (LPLS) and Improved Low-cost Phototherapy Light System (ILPLS) to the new Smart Low-cost Phototherapy Light System (Smart LPLS) with non-invasive jaundice monitoring for newborns with Neonatal Jaundice (NNJ).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |